Trimethylamine N-oxide
Abstract
No available
References
Obeid R, Awwad HM, Rabagny Y, Graeber S, Herrmann W, Geisel J. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids,
and methyl metabolism. Am J Clin Nutr 2016;103(3):703-11.
Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013;19(5):576-85.
Wilson A, McLean C, Kim RB. Trimethylamine-Noxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis. Curr Opin Lipidol 2016;27(2):148-54.
Chhibber-Goel J, Gaur A, Singhal V, Parakh N, Bhargava B, Sharma A. The complex metabolism of trimethylamine in humans: endogenous and exogenous
sources. Expert Rev Mol Med 2016;29;18:e8.
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011;472(7341):57-63.
Bäckhed F. Meat-metabolizing bacteria in atherosclerosis. Nat Med 2013;19(5):533-4.
Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, R_ber L, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic
marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J 2017;38(11): 814-24.
Tang WHW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes
to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 2015; 116(3):448-55.
Stubbs JR, House JA, Ocque AJ, Zhang S, Johnson C, Kimber C, et al. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol JASN 2016; 27(1):305-13.
Shafi T, Powe NR, Meyer TW, Hwang S, Hai X,Melamed ML, et al. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. J Am Soc Nephrol JASN 2017;28(1):321-31.
Randrianarisoa E, Lehn-Stefan A, Wang X, Hoene M, Peter A, Heinzmann SS, et al. Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early
Atherosclerosis in Humans. Sci Rep 2016;6:26745.
Senthong V, Li XS, Hudec T, Coughlin J, Wu Y, Levison B, et al. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite,
Is Associated With Atherosclerotic Burden. J Am Coll Cardiol 2016;67(22):2620-8.
Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, et al. Microbiota-dependent metabolite trimethylamine- N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med 2015;277(6):717-26.
Moraes C, Fouque D, Amaral ACF, Mafra D. Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet. J Ren Nutr
Off J Counc Ren Nutr Natl Kidney Found 2015;25(6): 459-65.
Cho CE, Taesuwan S, Malysheva OV, Bender E, Tulchinsky NF, Yan J, et al. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among
healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial.Mol Nutr Food Res 2017;61(1).
Miller CA, Corbin KD, da Costa K-A, Zhang S, Zhao X, Galanko JA, et al. Effect of egg ingestion on trimethylamine- N-oxide production in humans: a randomized,
controlled, dose-response study1234. Am J Clin Nutr 2014;100(3):778-86.
Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl
J Med 2013;368(17):1575-84.
DiMarco DM, Missimer A, Murillo AG, Lemos BS, Malysheva OV, Caudill MA, et al. Intake of up to 3 Eggs/Day Increases HDL Cholesterol and Plasma
Choline While Plasma Trimethylamine-N-oxide is Unchanged in a Healthy Population. Lipids 2017; 52(3):255-63.
Barrett EL, Kwan HS. Bacterial reduction of trimethylamine oxide. Annu Rev Microbiol 1985;39:131-49.
Chen M, Yi L, Zhang Y, Zhou X, Ran L, Yang J, et al. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating
TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. mBio 2016;7(2): e02210-15.
Kuka J, Liepinsh E, Makrecka-Kuka M, Liepins J, Cirule H, Gustina D, et al. Suppression of intestinal microbiota-dependent production of pro-atherogenic
trimethylamine N-oxide by shifting L-carnitine microbial degradation. Life Sci 2014;117(2):84-92.
Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell 2015;163(7):1585-95.
Shih DM, Wang Z, Lee R, Meng Y, Che N, Charugundla S, et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J Lipid Res 2015; 56(1):22-37.
Velasquez MT, Ramezani A, Manal A, Raj DS. Trimethylamine N-Oxide: The Good, the Bad and the Unknown. Toxins 2016;8(11).
Downloads
Published
How to Cite
Issue
Section
License
The content and information in the articles published in Thai JPEN วารสารโภชนบำบัด, are the opinions and responsibility of the authors directly. The editorial team is not obliged to agree or take any responsibility.
All articles, content, figures, etc. that have been published in Thai JPEN วารสารโภชนบำบัด are the copyright of Thai JPEN วารสารโภชนบำบัด. If any person or organization require distribution of all or any part of them, please send the request for the written permission from Thai JPEN วารสารโภชนบำบัด only.
